Wolverine Trading
VRNA

Wolverine Trading’s Verona Pharma VRNA Stock Holding History

Wolverine Trading’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$747K Buy
7,008
+4,088
+140% +$427K ﹤0.01% 3225
2025
Q2 		$274K Sell
2,920
-18,753
-87% -$1.39M ﹤0.01% 3580
2025
Q1 		$1.36M Buy
21,673
+3,393
+19% +$203K ﹤0.01% 1966
2024
Q4 		$860K Buy
+18,280
New +$686K ﹤0.01% 2812

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading's VRNA Position: Q3 2025 in Review

Wolverine Trading increased its Verona Pharma (VRNA) stake by 140% in Q3 2025, buying an estimated $427K and bringing the position to 7,008 shares worth $747K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

Wolverine Trading first reported a position in VRNA in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.36M in Q1 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Wolverine Trading held 7,008 shares of Verona Pharma worth $747K as of Q3 2025.
  • Wolverine Trading bought 4,088 Verona Pharma shares in Q3 2025, an estimated $427K.
  • Verona Pharma made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3225 holding.
  • Wolverine Trading first reported a position in Verona Pharma in Q4 2024 and has held it in 4 quarters since.
  • Wolverine Trading's Verona Pharma position peaked at $1.36M in Q1 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.